BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 1733508)

  • 1. Evidence for involvement of TNF-alpha in the induction phase and IFN-beta in the effector phase of antiproliferative activity of splenic macrophages.
    Stout RD; Suttles J
    Cell Immunol; 1992 Feb; 139(2):363-74. PubMed ID: 1733508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tumour necrosis factor-alpha in combination with interferon-gamma or interleukin-1 in the induction of immunosuppressive macrophages because of Mycobacterium avium complex infection.
    Tomioka H; Maw WW; Sato K; Saito H
    Immunology; 1996 May; 88(1):61-7. PubMed ID: 8707352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages.
    Stout RD; Bottomly K
    J Immunol; 1989 Feb; 142(3):760-5. PubMed ID: 2464024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.
    Langermans JA; Van der Hulst ME; Nibbering PH; Hiemstra PS; Fransen L; Van Furth R
    J Immunol; 1992 Jan; 148(2):568-74. PubMed ID: 1729374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor-alpha production by macrophages is induced by the synergistic action of interferon (IFN)-gamma and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN-gamma and IL 4.
    Stenger S; Solbach W; Röllinghoff M; Bogdan C
    Eur J Immunol; 1991 Jul; 21(7):1669-75. PubMed ID: 1905642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of tumor necrosis factor, interferon-gamma, transforming growth factor-beta, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection.
    Tomioka H; Sato K; Maw WW; Saito H
    J Leukoc Biol; 1995 Dec; 58(6):704-12. PubMed ID: 7499969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phagocytosis enhances murine macrophage activation by interferon-gamma and tumor necrosis factor-alpha.
    Corradin SB; Buchmüller-Rouiller Y; Mauël J
    Eur J Immunol; 1991 Oct; 21(10):2553-8. PubMed ID: 1915557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
    Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
    J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.
    Drapier JC; Wietzerbin J; Hibbs JB
    Eur J Immunol; 1988 Oct; 18(10):1587-92. PubMed ID: 3142779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages.
    Hatzigeorgiou DE; He S; Sobel J; Grabstein KH; Hafner A; Ho JL
    J Immunol; 1993 Oct; 151(7):3682-92. PubMed ID: 8397259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine secretion of interferon-alpha/beta and tumour necrosis factor-alpha synergistically activates mouse macrophages after infection with herpes simplex virus type 2.
    Ellermann-Eriksen S
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2191-9. PubMed ID: 8409942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon.
    Heise MT; Pollock JL; O'Guin A; Barkon ML; Bormley S; Virgin HW
    Virology; 1998 Feb; 241(2):331-44. PubMed ID: 9499808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
    Alleva DG; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of immunosuppressive functions of murine peritoneal macrophages induced with various agents.
    Tomioka H; Saito H
    J Leukoc Biol; 1992 Jan; 51(1):24-31. PubMed ID: 1740643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of a human salivary gland cell line.
    Wu AJ; Kurrasch RH; Katz J; Fox PC; Baum BJ; Atkinson JC
    J Cell Physiol; 1994 Nov; 161(2):217-26. PubMed ID: 7962105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages.
    Polsinelli T; Meltzer MS; Fortier AH
    J Immunol; 1994 Aug; 153(3):1238-45. PubMed ID: 8027551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma.
    Bermudez LE
    J Immunol; 1993 Mar; 150(5):1838-45. PubMed ID: 8436819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma.
    Alleva DG; Burger CJ; Elgert KD
    Scand J Immunol; 1994 Jan; 39(1):31-8. PubMed ID: 7904773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha triggers antitoxoplasmal activity of IFN-gamma primed macrophages.
    Sibley LD; Adams LB; Fukutomi Y; Krahenbuhl JL
    J Immunol; 1991 Oct; 147(7):2340-5. PubMed ID: 1918966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha.
    Alleva DG; Burger CJ; Elgert KD
    Immunopharmacology; 1993; 25(3):215-27. PubMed ID: 8354638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.